Skip to main content
Premium Trial:

Request an Annual Quote

Howard Robin, John Maraganore, Steve Kriegsman, Bob Towarnicki, John Spears, Dale Pfost, and Sam Reich

Premium

The Biotechnology Industry Organization’s annual BIO-CEO conference on Feb. 23-24 is featuring an RNAi discussion panel this year featuring six top industry exectives.

Sirna Therapeutics’ president and CEO Howard Robin is set to present, as is Alnylam Pharmaceuticals’ president and CEO John Maraganore.

Additional panel participants include CytRx president and CEO Steven Kriegsman, Nucleonics president and CEO Bob Towarnicki, Intradigm chairman and CEO John Spears, and Acuity Pharmaceuticals president and CEO Dale Pfost.

Representatives for Acuity also noted that the company’s co-founder and senior director of research Sam Reich is scheduled to take part in an ophthalmology discussion panel during the conference.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.